Induction of immunosuppression with OKT3 following heart transplantation: kidney function as a criterion for control of protocol duration.
Rodríguez
J A
JA
Heart Transplant Program, Hospital Juan Canalejo, La Coruña, Spain.
Crespo-Leiro
M G
MG
Paniagua
M J
MJ
Muñiz
J
J
Hermida
L F
LF
Fojón
S
S
Cuenca
J J
JJ
Juffé-Stein
A
A
Castro-Beiras
A
A
D016572:Cyclosporine / Q000097:blood / Q000627:therapeutic use*; D004334:Drug Administration Schedule; D006084:Graft Rejection / Q000453:epidemiology; D016027:Heart Transplantation / Q000276:immunology / Q000502:physiology*; D006801:Humans; D007165:Immunosuppression Therapy / Q000379:methods; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D007677:Kidney Function Tests; D016853:Muromonab-CD3 / Q000627:therapeutic use*; D012189:Retrospective Studies
D007166:Immunosuppressive Agents; D016853:Muromonab-CD3; D016572:Cyclosporine